| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/05/2001 | CA2304377A1 Peptide repeat immunogens |
| 04/04/2001 | EP1088555A1 Sustained-release preparation |
| 04/04/2001 | EP1088071A1 94 human secreted proteins |
| 04/04/2001 | EP1088070A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
| 04/04/2001 | EP1087996A2 Glycosulfopeptides and methods of synthesis and use thereof |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | CN1290270A Streptogramin derivatives prepartion method and compositions containing same |
| 04/03/2001 | US6211427 Peptide production as fusion protein in transgenic mammal milk |
| 04/03/2001 | US6211333 Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secreted from the hypothalamus |
| 04/03/2001 | US6211156 Peptides for treatment of erectile dysfunction |
| 04/03/2001 | US6211155 Stimulating immune system with peptides conjugated with mono-or dicarboxylic acid; |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6211145 Bicyclic depsipeptides |
| 04/03/2001 | US6210927 Polynucleotides encoding sbGnRH, a novel reproductive hormone |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | US6210902 Using two immunoassays to measure two different type 1 collagen breakdown products of defined amino acid sequence in sample and forming an index representing the difference in results; diagnosis of bone disorders such as osteoporosis |
| 04/03/2001 | US6210901 Modified hepatitis c virus amino acid sequence which binds to an antibody; for screening blood samples |
| 04/03/2001 | CA2183371C Pna combinatorial libraries and improved methods of synthesis |
| 03/29/2001 | WO2001021660A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | CA2793128A1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1086955A1 Peptides against antibodies elicited by DCM |
| 03/28/2001 | EP1086954A1 Peptides against autoantibodies elicited by DCM |
| 03/28/2001 | EP1086742A1 Combinatorial strategies for polymer synthesis |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086124A1 Novel cyclosporins |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085896A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
| 03/27/2001 | US6207644 Peptide analogues containing a 7-membered lactam ring |
| 03/27/2001 | US6207643 Mimetic insect allatostatin analogs for insect control |
| 03/27/2001 | US6207639 Contacting a neuron with a cell adhesion modulating peptide that comprises a cyclic peptide in which nonadjacent amino acid residues are covalently linked to form a peptide ring comprising sequence his-ala-val within cyclic peptide ring |
| 03/27/2001 | US6207456 Nucleic acid delivery vehicle |
| 03/27/2001 | US6207434 Efficient streptomyces acylase for production of cyclic peptides from substance fr901379 analogs |
| 03/27/2001 | US6207398 Lysing red blood cells in a sample of whole blood containing cyclosporin a, contacting the sample with excess of labeled anti-cyclosporin antibody to form a complex, separating unbound antibody, contacting complex with cyclosporins |
| 03/27/2001 | US6207160 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 03/27/2001 | CA2166297C Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/22/2001 | WO2001019852A2 Methods of peptide preparation |
| 03/22/2001 | WO2001001749A3 FVIIa ANTAGONISTS |
| 03/22/2001 | WO2000078793A3 Antimicrobial agents |
| 03/22/2001 | WO2000063240A9 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE) |
| 03/22/2001 | WO2000052037A8 Echinocandin/carbohydrate complexes |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2382544A1 Methods of peptide preparation |
| 03/21/2001 | EP1084409A1 Method and device for electrochemical immunoassay of multiple analytes |
| 03/21/2001 | EP1084239A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| 03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 03/21/2001 | EP1084133A1 Redox reversible bipyridyl osmium complex conjugates |
| 03/21/2001 | EP1084132A1 Redox reversible imidazole-osmium complex conjugates |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/20/2001 | US6204370 MN gene and protein |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204361 Method of peptide synthesis |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204326 Adding peptide nucleic acid units to an amine terminated peptide nucleic acid oligomer on a solid phase synthetic resin; biosynthesis |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/20/2001 | US6203788 Implanting cellular adhesion molecule and schwann or oligodendrocyte progenitor cell(s); inhibiting n-cadherin-mediated cell adhesion; treating muliple sclerosis |
| 03/20/2001 | CA2098303C Synthetic bioadhesive polypeptide |
| 03/15/2001 | WO2001018227A1 Novel compound f-15078 |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018032A2 Dolastatin peptides |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2383758A1 Novel compound f-15078 |
| 03/14/2001 | EP1083180A1 Method for searching physiologically active substances, process for producing theses substances and drugs found by the searching method |
| 03/14/2001 | EP1082340A1 Peptide vaccine for canine allergy |
| 03/14/2001 | EP1082339A2 Rationally designed peptides, production and use thereof |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082128A1 Lysine containing peptides for treatment of heart disease |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200546 Gastrin receptor-avid peptide conjugates |
| 03/08/2001 | WO2001016360A1 A rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 03/08/2001 | WO2001016211A1 Amphipathic compound having dendritic structure |
| 03/08/2001 | WO2001016163A2 Peptide mixture and vaccine against a chronic viral infection |
| 03/08/2001 | WO2001016162A1 Method for producing cyclic peptidomimetics |
| 03/08/2001 | WO2001016161A1 SYNTHESIS OF TEMPLATE-FIXED β-HAIRPIN LOOP MIMETICS |
| 03/08/2001 | WO2001016160A2 Purification and analysis of cyclic peptide libraries, and compositions thereof |
| 03/08/2001 | WO2001015737A2 Method for coupling molecules |
| 03/08/2001 | WO2001015720A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | WO2001015511A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 03/08/2001 | WO2000061766A3 Telomerase-specific cancer vaccine |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |